Christopher Ours, M.D., M.H.S.
Assistant Research Physician
Precision Genomics Section
Education
M.H.S. Duke University
M.D. New York Medical College
Last updated: November 7, 2023
Scan to visit
Precision Genomics Section
M.H.S. Duke University
M.D. New York Medical College
Dr. Ours is an Assistant Research Physician at the Center for Precision Health Research, NHGRI. He received his medical degree from New York Medical College; completed his residency in pediatrics from Wake Forest University in Winston-Salem, NC; and fellowship in pediatric hematology/oncology from the University of Utah. He then joined Dr. Leslie Biesecker’s laboratory to study rare segmental overgrowth disorders. While at NIH he received a master’s degree in Clinical Research through the NIH-Duke Clinical Research Training Program.
Dr. Ours research interests involve natural history studies of segmental overgrowth disorders which focus on Proteus syndrome, tumor predisposition, and molecularly undiagnosed mosaic overgrowth disorders (NCT00001403). He is the lead associate investigator of a clinical trial for the evaluation of the efficacy of miransertib, a pan-AKT inhibitor, in the Proteus syndrome study (NCT04316546).
Ferguson R, Scurr I, Ours CA, Johnston JJ, Pike K, & Spentzou G. Co-occurrence of Proteus syndrome and ventricular tachycardia cardiac arrest in a teenager. Am J Med Genet A. 2023;191 (5):1430-1433.
Ours CA, Hodges MB, Oden N, Sapp JC, & Biesecker LG. Development of the Clinical Gestalt Assessment: a visual clinical global impression scale for Proteus syndrome. Orphanet J Rare Dis. 2022;17(1):173.
Modlin EW, Slavotinek AM, Darling TN, Lipkowitz S, Barr FG, Munster PN, Biesecker LG, & Ours CA. Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma. Am J Med Genet A. 2022;188(9):2766-2771.
Ours CA, Biesecker LG, & Darling TN. Progression of skin lesions in Warburg-Cinotti syndrome. JAAD Case Rep. 2022;20:47-49.
Underwood JS, Ours C, Burns RC, & Ferguson MJ. Immature teratoma in an adolescent with Proteus syndrome: A novel association. Clin Case Rep. 2021;9(5):e04143.
Ours CA, Sapp JC, Hodges MB, de Moya AJ, Biesecker LG. Case report: Five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome. Cold Spring Harb Mol Case Stud. 2021;7(6):a006134.
Ours CA and Biesecker LG. Prophylactic anticoagulation of individuals with Proteus syndrome and COVID-19. Am J Med Genet A. 2020;182(12):2829-2831.
Last updated: November 7, 2023